FDA Clears Sulfanilamide Vaginal Cream for Sale, Citing Lack of Safety or Effectiveness Concerns

Summary

The US Food and Drug Administration (FDA) has ruled that the drug products listed in the document were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications (ANDAs) for these products as long as they meet relevant requirements.